搜尋結果
Slowing ALS Progression Through Gene Therapy
Forbes· 2 日前This story is part of a series on the current progression in Regenerative Medicine. In 1999, I ...
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 3 日前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...